Age and race disparities in cervical cancer diagnosis and treatment were found to be significant for both adenocarcinoma and squamous cell carcinoma between 2004 and 2017. Among patients with cancer of the cervix, there are…
MDNewsline DailyJanuary 17, 2023
Abdominal radical hysterectomy (ARH) is superior to radiochemotherapy (R-CT) in patients diagnosed with stage IB3 cervical cancer, according to the FIGO 2018 staging system, based on higher DFS and 5-year OS rates. Cervical cancer is…
Daysha RobinsonOctober 31, 2022
Socioeconomic factors are linked to disparities in HPV awareness and cervical cancer screening adherence. Cervical cancer is the 4th most common cancer in women worldwide and the 7th most common cancer overall. Family caregivers are…
Daysha RobinsonSeptember 21, 2022
There are racial/ethnic inequalities in cervical cancer screening in the United States, but an outcome reclassification may lead to better interventions. Data shows that cervical cancer mortality is preventable through early detection. Pap smears and…
Daysha RobinsonSeptember 20, 2022
Despite HPV vaccinations being widely available, HPV-associated cervical cancer still disproportionally affects Black and Latino women. Research finds that underserved women are less likely to receive HPV vaccine recommendations from their healthcare providers. Human papillomavirus…
Daysha RobinsonSeptember 20, 2022
This year, it is estimated that 14,100 women will be diagnosed with invasive cervical cancer in the United States . When compared to non-Hispanic white women, African American women have a significantly higher rate of…
Dr. Lauren WeinandAugust 7, 2022
Most accredited cancer programs in the United States reported a decline in cancer screening during the pandemic, most notably in colorectal cancer, according to a study published in Cancer. Rachel H. Joung, M.D., from the Northwestern…
Dr. Lauren WeinandMay 11, 2022
The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021. The…
Dr. Lauren WeinandMay 10, 2022
A COVID-19 diagnosis can lead to potentially life-threatening treatment delays for women with gynecological cancers, a new study finds. That's especially true for non-white patients, the researchers said. "We found that concurrent COVID-19 had significant…
Dr. Lauren WeinandMay 9, 2022
The recent decrease in the incidence of cervical cancers, particularly in young women, may be associated with human papillomavirus (HPV) vaccination approval, according to a study published in JAMA Network Open. Cheng-I Liao, M.D., from the…
Dr. Lauren WeinandMay 6, 2022